%A Lin Li, Zhou Fuxiang %T Stereotactic body radiotherapy for early stage nonsmall cell lung cancer %0 Journal Article %D 2015 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2015.10.015 %P 773-775 %V 42 %N 10 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9798.shtml} %8 2015-10-08 %X As one of the treatment options for early stage NSCLC, stereotactic body radiation therapy (SBRT) is mainly applied to the inoperable patients. Compared with small doses of traditional fractionated radiation treatment, SBRT are taken a single high dose of radiation. A large body of experience has been accumulated over the years and the mathematical model to describe survival in high dose range typically used in SBRT and the best dose of segmentation model were focused on, but there has not yet reached a consensus. Studies show that SBRT has certain advantages in local control ratio and adverse reaction compared with traditional radiotherapy, which can be used in operable patients in the future.